Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Outcomes indicators and processes in transitional care in adolescents with haemophilia: A Delphi survey of Canadian haemophilia care providers.

Sun HL, Breakey VR, Straatman L, Wu JK, Jackson S.

Haemophilia. 2019 Mar;25(2):296-305. doi: 10.1111/hae.13699. Epub 2019 Feb 28.

PMID:
30817086
2.

Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.

Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon MC, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS.

Lancet Haematol. 2018 Jun;5(6):e252-e260. doi: 10.1016/S2352-3026(18)30048-6. Epub 2018 May 3.

PMID:
29731369
3.

Prevalence of Vitamin D Deficiency Varies Widely by Season in Canadian Children and Adolescents with Sickle Cell Disease.

Samson KLI, McCartney H, Vercauteren SM, Wu JK, Karakochuk CD.

J Clin Med. 2018 Jan 30;7(2). pii: E14. doi: 10.3390/jcm7020014.

4.

The clinical impact of copy number variants in inherited bone marrow failure syndromes.

Waespe N, Dhanraj S, Wahala M, Tsangaris E, Enbar T, Zlateska B, Li H, Klaassen RJ, Fernandez CV, Cuvelier GDE, Wu JK, Pastore YD, Silva M, Lipton JH, Brossard J, Michon B, Abish S, Steele M, Sinha R, Belletrutti MJ, Breakey VR, Jardine L, Goodyear L, Kofler L, Cada M, Sung L, Shago M, Scherer SW, Dror Y.

NPJ Genom Med. 2017 May 10;2. pii: 18. doi: 10.1038/s41525-017-0019-2.

5.

Further Validation of the SIGMAR1 c.151+1G>T Mutation as Cause of Distal Hereditary Motor Neuropathy.

Lee JJY, van Karnebeek CDM, Drögemoller B, Shyr C, Tarailo-Graovac M, Eydoux P, Ross CJ, Wasserman WW, Björnson B, Wu JK.

Child Neurol Open. 2016 Sep 26;3:2329048X16669912. doi: 10.1177/2329048X16669912. eCollection 2016 Jan-Dec.

6.

Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease.

Casey LJ, Tuttle A, Grabell J, Hopman W, Moorehead PC, Blanchette VS, Wu JK, Steele M, Klaassen RJ, Silva M, Rand ML, James PD.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26588. Epub 2017 Apr 28.

PMID:
28453185
7.

Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease.

Bhuller KS, Heran MK, Wu JK, Rassekh SR.

Pediatr Blood Cancer. 2014 Dec;61(12):2321-3. doi: 10.1002/pbc.25155. Epub 2014 Jul 22.

PMID:
25053422
8.

Factor XIII deficiency management: a review of the literature.

Odame JE, Chan AK, Wu JK, Breakey VR.

Blood Coagul Fibrinolysis. 2014 Apr;25(3):199-205. doi: 10.1097/MBC.0000000000000029. Review.

PMID:
24401950
9.

Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations.

Prestidge TD, Rurali E, Wadsworth L, Wu JK, Moore JC, Bresin E.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1296-8. doi: 10.1002/pbc.24159. Epub 2012 Apr 5.

PMID:
22488907
10.

In Utero diagnosis and management of a fetus with homozygous α-Thalassemia in the second trimester: a case report and literature review.

Dwinnell SJ, Coad S, Butler B, Albersheim S, Wadsworth LD, Wu JK, Delisle MF.

J Pediatr Hematol Oncol. 2011 Dec;33(8):e358-60. doi: 10.1097/MPH.0b013e31821b368c. Review.

PMID:
22042285
11.

Case 2: A pale infant - not a typical case of iron deficiency.

Wong MP, Wadsworth L, Wu JK, Dix D.

Paediatr Child Health. 2008 Jul;13(6):507-11. No abstract available.

12.

Molecular determination of the breakpoints of a 161 556 bp deletion at chromosome 13q34 that presented as severe factor VII deficiency in a neonate.

Hewitt J, Craven SJ, Brown LA, Bleackley MR, Ballard JN, Smith VC, Ofosu FA, Huntsman DG, Wadsworth LD, Wu JK, Macgillivray RT.

Br J Haematol. 2008 Mar;140(5):589-92. Epub 2007 Dec 19. No abstract available.

PMID:
18162117
13.

Diagnosing platelet delta-storage pool disease in children by flow cytometry.

Maurer-Spurej E, Pittendreigh C, Wu JK.

Am J Clin Pathol. 2007 Apr;127(4):626-32.

PMID:
17369140
14.

Malignant hypertension, polycythemia, and paragangliomas.

Dionne JM, Wu JK, Heran M, Murphy JJ, Jevon G, White CT.

J Pediatr. 2006 Apr;148(4):540-5. No abstract available.

PMID:
16647420
15.

Hemorrhagic pseudotumour of the maxillary sinus.

Lee PK, Wu JK, Ludemann JP.

J Otolaryngol. 2004 Jun;33(3):206-8. No abstract available.

PMID:
15842005
16.

Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion.

Hewitt J, Ballard JN, Nelson TN, Smith VC, Griffiths TA, Pritchard S, Wu JK, Wadsworth LD, Casey B, MacGillivray RT.

Br J Haematol. 2005 Feb;128(3):380-5.

PMID:
15667541
17.

Utility of anti-xa monitoring in children receiving enoxaparin for therapeutic anticoagulation.

Leung M, Ho SH, Hamilton DP, Wu JK, Dix DB, Wadsworth LD, Ensom MH.

J Pediatr Pharmacol Ther. 2005 Jan;10(1):43-50. doi: 10.5863/1551-6776-10.1.43.

18.

Hyperuricemia and reticulocytopenia in association with autoimmune hemolytic anemia in two children.

Jastaniah WA, Pritchard SL, Wu JK, Wadsworth LD.

Am J Clin Pathol. 2004 Dec;122(6):849-54.

PMID:
15539377
19.

An assessment of published pediatric dosage guidelines for enoxaparin: a retrospective review.

Ho SH, Wu JK, Hamilton DP, Dix DB, Wadsworth LD.

J Pediatr Hematol Oncol. 2004 Sep;26(9):561-6.

PMID:
15342982
20.

Beta-thalassemia in association with a new delta-chain hemoglobin variant [delta116(g18)Arg-->Leu]: implications for carrier screening and prenatal diagnosis.

Waye JS, Patterson M, Walker L, Eng B, Nakamura LM, Lafferty JD, Yong SL, Wu JK, Chui DH.

Am J Hematol. 2003 Nov;74(3):179-81. Erratum in: Am J Hematol. 2004 May;76(1):99. Yong, Sui-Li [corrected to Yong, Siu-Li].

Supplemental Content

Loading ...
Support Center